Prescribing change, expecting more
A major study of 1.3 million women has suggested that antipsychotic use during pregnancy does not significantly increase the risk of birth defects. The research, carried out at Harvard Medical School, also found that there was no enhanced risk of cardiac malformations in particular. Exposure to antipsychotics during pregnancy is increasingly common, said the researchers. Antipsychotic medications are used for…
Read more > New study suggests antipsychotic use not linked to birth defects
We are now over a month into a new regime in the U.S. that paves the way for pregnant women to be better provided for. As of June 30, the Food and Drug Administration (FDA) revised the rules on the labeling of prescription drugs, meaning that doctors have more information and women can expect better advice. “Prescribing decisions during pregnancy…
Read more > New FDA ruling may spark research into pregnancy and medication says ACOG
Lode Dewulf has studied and practiced medicine and worked in the pharmaceutical industry for more than 25 years. Outspoken on the rights of pregnant women to receive information and treatment, Dr. Dewulf took part in the recent European Gender Medicine Network (EUGenMed) Sex and Gender conference at the at the European Economic and Social Commission, giving a talk entitled “Safe…
